{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:00Z","timestamp":1761895920252},"reference-count":23,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/mco.2014.346","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T13:11:55Z","timestamp":1405084315000},"page":"1107-1110","source":"Crossref","is-referenced-by-count":7,"title":["Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer"],"prefix":"10.3892","volume":"2","author":[{"given":"WAHID","family":"MDAH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RANEEN","family":"MZALBAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PETER","family":"GILBEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOSHE","family":"STEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ADI","family":"SHARABI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMAL","family":"ZIDAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,7,11]]},"reference":[{"key":"key20180107151022_b1-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2000.18.11.2201","article-title":"C-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems","volume":"18","author":"Allgayer","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180107151022_b2-mco-02-06-1107","first-page":"985","article-title":"Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract","volume":"4","author":"Zhang","year":"1989","journal-title":"Oncogene"},{"key":"key20180107151022_b3-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(86)91782-4","article-title":"Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo","volume":"8484","author":"Yokota","year":"1986","journal-title":"Lancet"},{"key":"key20180107151022_b4-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711610305","article-title":"The c-erbB-2 proto-oncogene in pancreatic cancer","volume":"161","author":"Hall","year":"1990","journal-title":"J Pathol"},{"key":"key20180107151022_b5-mco-02-06-1107","first-page":"1233","article-title":"Expression of the c-erbB-2 gene product (185) at different stages of neoplastic progression in the colon","volume":"4","author":"D\u2019Emilia","year":"1989","journal-title":"Oncogene"},{"key":"key20180107151022_b6-mco-02-06-1107","first-page":"1199","article-title":"Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities","volume":"57","author":"Tan","year":"1997","journal-title":"Cancer Res"},{"key":"key20180107151022_b7-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"key20180107151022_b8-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107151022_b9-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for HER2-positive advanced gastric or gastro-esophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"key20180107151022_b10-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.20691","article-title":"Anaplastic thyroid cancer and primary thyroid lymphoma: A review of these rare thyroid malignancies","volume":"94","author":"Green","year":"2006","journal-title":"J Surg Oncol"},{"key":"key20180107151022_b11-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0","article-title":"Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991","volume":"79","author":"Gilliland","year":"1997","journal-title":"Cancer"},{"key":"key20180107151022_b12-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherman","year":"2003","journal-title":"Lancet"},{"key":"key20180107151022_b13-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1200\/JCO.2007.15.9566","article-title":"Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study","volume":"26","author":"Cohen","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107151022_b14-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2008.16.3279","article-title":"Phase II trial of sorafenib in advanced thyroid cancer","volume":"26","author":"Gupta-Abramson","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107151022_b15-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0277-5379(90)90149-N","article-title":"Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia","volume":"26","author":"Lemoine","year":"1990","journal-title":"Eur J Cancer"},{"key":"key20180107151022_b16-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/bjc.1992.177","article-title":"Expression of c-erbB-2 protein in papillary thyroid carcinomas","volume":"65","author":"Haugen","year":"1992","journal-title":"Br J Cancer"},{"key":"key20180107151022_b17-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I","article-title":"The WHO histological classification of thyroid tumors: a commentary on the second edition","volume":"63","author":"Hedinger","year":"1989","journal-title":"Cancer"},{"key":"key20180107151022_b18-mco-02-06-1107","first-page":"131","volume-title":"International Union Against Cancer: TNM Classification of Malignant Tumours","author":"UICC","year":"2002","edition":"6th edition"},{"key":"key20180107151022_b19-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00428-003-0769-3","article-title":"Her2\/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease","volume":"442","author":"Kremser","year":"2003","journal-title":"Virchows Arch"},{"key":"key20180107151022_b20-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2559.1999.00563.x","article-title":"Expression of c-erbB-2 oncoprotein in human thyroid tumours","volume":"34","author":"Utrilla","year":"1999","journal-title":"Histopathology"},{"key":"key20180107151022_b21-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2265.1998.00580.x","article-title":"Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia","volume":"49","author":"Sugg","year":"1998","journal-title":"Clin Endocrinol"},{"key":"key20180107151022_b22-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2559.1989.tb01587.x","article-title":"The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues","volume":"15","author":"de Potter","year":"1989","journal-title":"Histopathology"},{"key":"key20180107151022_b23-mco-02-06-1107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bjc.1991.139","article-title":"Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder","volume":"63","author":"Coombs","year":"1991","journal-title":"Br J Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.346\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T06:08:31Z","timestamp":1598076511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,11]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,7,11]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/mco.2014.346"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.346","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,11]]}}}